CytoDyn Stock Price (OTCMKTS:CYDY)

Add to My Stocks
$0.63 $0.01 (1.56%) CYDY stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.64
Market Cap:
$146.66M
Day Low: $0.62
52 Week Low: $0.40
Open: $0.64
Volume: -
Day High: $0.65
52 Week High: $0.84
Dividend:
0.00

Latest Stock Market News

Latest Articles

CytoDyn News - From Partners

CYDY Stockcharts

View CYDY PE ratio, PS ratio stocks charts and compare with peers.
CYDY Chart
Note: Compare CytoDyn stock price history with the index and industry peers.

CytoDyn Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

CytoDyn Returns

ROE
(return on equity)

CytoDyn Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

CYDY Industry Peers

Company Price Change (%)
Fennec Pharma (FENC)8.30.08 (0.97%)
Forward Pharma (FWP)2.590.2 (7.17%)
Sarepta Therapeutics (SRPT)153.581.23 (0.81%)
Biocryst Pharma (BCRX)7.150.17 (2.44%)
Chimerix (CMRX)3.780.07 (1.89%)
Nanoviricides (NNVC)0.410.02 (5.13%)
Spring Bank Pharma (SBPH)11.540.08 (0.7%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

CytoDyn Inc Stock News - Partner Headlines

CytoDyn Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-25.76M-25.7M-25.08M-12.43M-9.56M
Total Operating Expense26.95M20.82M19.22M7.75M7.15M
View CytoDyn income statement
balance sheet20172016201520142013
Total Assets8.05M13.78M4.67M8.42M4.15M
Total Liabilities9.15M3.58M15.37M4.5M4.38M
Shareholders Equity-1.1M10.2M-10.69M3.92M-0.22M
View CytoDyn balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.98M-6.27M6.94M-0.17M1.03M
Net Cash from (used by) Operating Activities-26.73M-24.81M-12.01M-7.38M-3.39M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.01M-0.01M-0.01M-
View CytoDyn cash flow statement

CytoDyn Stock Message Board

CytoDyn stock lost 1.56%, and the last close price as of Sep 18, 2018 is $0.63 for CYDY stock. Stock price or share price can be used to find the total market value of a company. CytoDyn market cap stands at $146.66M as of Sep 18, 2018. A value investor must look at the fundamentals of a stock, and perform CytoDyn valuation, even though in the short-term, sentiment and current breaking news might affect CytoDyn stock price.

For recognizing and analyzing the real performance of CytoDyn stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in CytoDyn stock quote data shows the number of shares traded. For Ex: 139,286 CytoDyn shares were traded as of last trading day, as seen from CytoDyn stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. CytoDyn dividend per share was 0.00 during the last quarter. CytoDyn stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.